TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease (NCT05615233) | Clinical Trial Compass
CompletedNot Applicable
TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease
United States54 participantsStarted 2024-04-05
Plain-language summary
The purpose of the proposed study is to preliminarily evaluate Technology-based information and coaching/support program that is tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease (TACAD) in improving health outcomes of Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA) and their care recipients.
Who can participate
Age range
40 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* self reported Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA).
* Participants will be included if, by self-report, they are Asian American women aged 40 to 65 years old who identify as Chinese or Korean;
* are family caregivers of PLAD;
* can read and write English, Mandarin Chinese or Korean;
* who reside in the U.S.;
* have access to the Internet through computers or mobile devices.
* Participants must be providing at least 4 hours per day unpaid assistance, on average, for a community-dwelling person in the early-middle stage of illness (Clinical Dementia Rating of 1) for whom there is no plan for institutionalization in six months.
* Caregivers may or may not reside with their care recipient.
Exclusion Criteria:
* Those who used the AA website previously and/or participated in other studies related to AD will be excluded.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Multidimensional Caregiver Strain Index from baseline
Timeframe: Baseline, 1 months post intervention, 3 months post intervention
2
Change in Perceived Stress Scale score from baseline
Timeframe: Baseline, 1 months post intervention, 3 months post intervention
3
Change in Acculturation Stress Scale (ASS) score from baseline
Timeframe: Baseline, 1 months post intervention, 3 months post intervention
4
Change in Social Readjustment Rating Scale (SRRS) score from baseline
Timeframe: Baseline, 1 months post intervention, 3 months post intervention
5
Change in Midlife Women's Symptom Index from baseline
Timeframe: Baseline, 1 months post intervention, 3 months post intervention
6
Change in EQ-5D-5L scale score from baseline
Timeframe: Baseline, 1 months post intervention, 3 months post intervention
7
Change in Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) score from baseline